Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 01 Feb 2022 |
2 | Reply to Exam Report (MIS-R) | 10 Apr 2022 |
3 | TM-M(REQUEST FOR PAYMENT OF MISC. FEE FOR OTHER PURPOSE) | 10 Apr 2022 |
4 | Journal Copy | 09 Nov 2023 |
5 | TM-O(NOTICE OF OPPOSITION) | 05 Dec 2023 |
6 | TM-O(NOTICE OF OPPOSITION) | 05 Dec 2023 |
1 | EXAMINATION REPORT | 13177193 | 14 Mar 2022 | |
2 | Hearing Notice (Show Cause) | 15470111 | 21 Jun 2023 | |
3 | Tribunal Accepted Notice for : 5308306 | 15730551 | 6089170 | 31 Jul 2023 |
4 | Opposition Notice | 16738523 | 6373295 | 06 Dec 2023 |
5 | Opposition Notice | 16738563 | 6373319 | 06 Dec 2023 |
6 | Order Form of 21(2) | 17753221 | 6642795 | 18 Mar 2024 |
7 | Order Form of 21(2) | 17753222 | 6642797 | 18 Mar 2024 |
The application for Qystien was made on 01 February 2022.
The trademark applicant for Qystien is QUESTUS PHARMA.
Qystien is applied in class(es) 5.
Application for Qystien is on Abandoned stage.
Application Id allotted to Qystien is 5308306.
Trademark agent or attorney for the application is I Sreenivasa Murthy.
Qystien filed with the Intellectual property office as a WORD.